Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats

被引:29
|
作者
Wang, Jianping [1 ]
Zhang, Qing [1 ]
Mei, Xiuhua [1 ]
Zhang, Xiuzhen [1 ]
机构
[1] Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China
关键词
Anti-apoptosis; metalloproteinases; Hydroxysafflor Yellow A; left cardiac remodeling; left ventricular remodeling; MATRIX-METALLOPROTEINASE INHIBITION; ESSENTIAL-HYPERTENSION; DYSFUNCTION; APOPTOSIS; MORBIDITY; BCL-2; MASS;
D O I
10.3109/13880209.2013.805791
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Context: Hydroxysafflor yellow A (HSYA), the main chemical component of the safflower yellow pigments, is used extensively in traditional Chinese medicine for the treatment of cerebrovascular and cardiovascular diseases. Objective: The present study determined the effects of HSYA on left ventricular hypertrophy after pressure overload and investigated the underlying mechanisms. Materials and methods: Cardiac hypertrophy was induced by the ligation of abdominal aorta in male Wistar rats. The rats were then divided into five groups and treated with captopril (100 mg/kg) or HSYA at different doses (0, 10, 20 and 40 mg/kg). Six weeks after treatment, the weight of left ventricle, LVMI (left ventricular mass index) and pathological changes were measured. MMP-2 (metalloproteinase 2) and MMP-9 (metalloproteinase 9) levels were determined by ELISA. Protein expressions of Bcl-2 and Bax were evaluated by immunohistochemistry. Results: HSYA (20, 40 mg/kg) significantly attenuated the increase of LVMI (ventricular weight/body weight) by 13.04 and 30.43% respectively, when compared with the model group. This was associated with the amelioration of pathological lesion, such as cardiac muscle fibers were smaller and the nuclei of cardiomyocytes were lightly stained in animals treated with HSYA (20, 40 mg/kg). In addition, the administration of HSYA at doses of 20 and 40 mg/kg increased the Bcl-2/Bax ratio (1.17 +/- 0.08 and 1.39 +/- 0.07 versus 0.71 +/- 0.06). In addition, the serum MMP-2 and MMP-9 levels were blocked by the treatment at doses of 20 and 40 mg/kg HSYA (MMP-2, 76.1 +/- 9.2 and 65.6 +/- 6.8 versus 82.9 +/- 6.2, ng/ml; MMP-9, 66.6 +/- 4.8 and 57.5 +/- 5.0 versus 83.5 +/- 6.0, ng/ml). Conclusion: These findings indicated that HSYA has beneficial effects on hypertensive ventricular remodeling, which may involve mechanisms of inhibiting cell apoptosis and suppressing metalloproteinases expression.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [41] Alteration in myocardial prostaglandin D synthase expression in pressure overload-induced left ventricular remodeling in rats
    Nagalla, Krishna T.
    Gole, Monica
    Claudino, Mario A.
    Gardner, Jason D.
    Murray, David B.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 237 (01) : 24 - 30
  • [42] Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy
    Ramos-Kuri, Manuel
    Rapti, Kleopatra
    Mehel, Hind
    Zhang, Shihong
    Dhandapany, Perundurai S.
    Liang, Lifan
    Garcia-Carranca, Alejandro
    Bobe, Regis
    Fischmeister, Rodolphe
    Adnot, Serge
    Lebeche, Djamel
    Hajjar, Roger J.
    Lipskaia, Larissa
    Chemaly, Elie R.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (11): : 2870 - 2884
  • [43] Atorvastatin Attenuates Pressure Overload-induced Cardiac Hypertrophy and Dysfunction Through Enhanced Autophagy
    Zhao, Zhuo
    Wang, Wei
    Wang, Hua-Ting
    Geng, Qing-Xin
    Zhao, Di
    Su, Guohai
    CIRCULATION RESEARCH, 2015, 117
  • [44] Hawthorn alters remodeling and ameliorates LV dysfunction in pressure overload-induced cardiac hypertrophy
    Hwang, Hyun Seok
    Ghannam, Michael M. J.
    Boluyt, Marvin O.
    Converso, Kimber
    Russell, Mark W.
    Bleske, Barry E.
    FASEB JOURNAL, 2007, 21 (06): : A1260 - A1260
  • [45] Remodeling of the guinea pig intracardiac plexus following pressure overload-induced cardiac hypertrophy
    Baran, Caitlin N.
    Southerland, E. Marie
    Ardell, Jeffery L.
    Hardwick, Jean C.
    FASEB JOURNAL, 2008, 22
  • [46] Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice
    Velten, Markus
    Duerr, Georg D.
    Pessies, Thilo
    Schild, Julia
    Lohner, Ralph
    Mersmann, Jan
    Dewald, Oliver
    Zacharowski, Kai
    Klaschik, Sven
    Hilbert, Tobias
    Hoeft, Andreas
    Baumgarten, Georg
    Meyer, Rainer
    Boehm, Olaf
    Knuefermann, Pascal
    CARDIOVASCULAR RESEARCH, 2012, 96 (03) : 422 - 432
  • [47] SLIT3 deficiency attenuates pressure overload-induced cardiac fibrosis and remodeling
    Gong, Lianghui
    Wang, Shuyun
    Shen, Li
    Liu, Catherine
    Shenouda, Mena
    Li, Baolei
    Liu, Xiaoxiao
    Shaw, John A.
    Wineman, Alan L.
    Yang, Yifeng
    Xiong, Dingding
    Eichmann, Anne
    Evans, Sylvia M.
    Weiss, Stephen J.
    Si, Ming-Sing
    JCI INSIGHT, 2020, 5 (12)
  • [48] Apigenin inhibits pressure overload-induced cardiac hypertrophy
    Dong, Xuan
    Zhou, Heng
    Zhang, Yan
    Xu, Man
    Hao, Yarong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3772 - 3778
  • [49] Therapeutic Cardiac-Targeted Delivery of miR-1 Reverses Pressure Overload-Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
    Karakikes, Ioannis
    Chaanine, Antoine H.
    Kang, Soojeong
    Mukete, Bertrand N.
    Jeong, Dongtak
    Zhang, Shihong
    Hajjar, Roger J.
    Lebeche, Djamel
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02):
  • [50] SEPIAPTERIN INHIBITS ADAPTIVE LEFT VENTRICULAR HYPERTROPHY BUT PREVENTS DILATORY REMODELING INDUCED BY PRESSURE OVERLOAD IN RATS
    Yoshioka, Kei
    Otani, Hajime
    Shimazu, Takayuki
    Fujita, Masanori
    Okazaki, Toru
    Sato, Daisuke
    IwasakA, Toshiji
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E214 - E214